Methotrimeprazine
- Generic Name
- Methotrimeprazine
- Brand Names
- Nozinan
- Drug Type
- Small Molecule
- Chemical Formula
- C19H24N2OS
- CAS Number
- 60-99-1
- Unique Ingredient Identifier
- 9G0LAW7ATQ
- Background
A phenothiazine with pharmacological activity similar to that of both chlorpromazine and promethazine. It has the histamine-antagonist properties of the antihistamines together with central nervous system effects resembling those of chlorpromazine. (From Martindale, The Extra Pharmacopoeia, 30th ed, p604)
- Indication
For the treatment of psychosis, particular those of schizophrenia, and manic phases of bipolar disorder.
- Associated Conditions
- Amnesia-Memory Loss, Anxiety, Bipolar Disorder (BD), Cancer Pain, Nausea and vomiting, Phantom Limb Pain (PLP), Postherpetic Neuralgia, Schizophrenia, Senile psychosis, Trigeminal Neuralgia (TN), Neurocostal neuralgia
- Associated Therapies
- Perioperative analgesia
No news found
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath